StockData
Mustang Bio, Inc. logo

Mustang Bio, Inc. (MBIO) stock

MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)

Close on Nov 18, 2026Market cap $2.88MP/E –Yield –

How the market prices Mustang Bio

Each ratio against its own distribution since 2017, from month-end prices and the figures reported at the time

Mustang Bio trades at 0.4× its earnings, against a median of 2.4× since 2017 — cheaper than 94% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2017, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to book since 2017

Median 2.4×, today 0.4×

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-58.1%vs -53.3%
Return on assets-21.2%vs -40.6%
Return on capital employed-45.8%vs -38.7%

How hard the assets work

Profit per employee-$758.25Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $15.15M.

Cash and short-term investments$15.15M
EBITDA, trailing twelve months-$3.52M

Leverage and liquidity

Quick ratio1.91vs 2.37

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

-36.46
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

3 of 9 tests passed

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield-105.3%vs -23.6%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 18, 2026

$0.3552-week low52-week high$1.43
$0.3820-day50-day200-day

The close sits 3% of the way up the 52-week range, 73.4% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

43
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

MBIOS&P 500
PeriodMBIOS&P 500DifferenceMBIO per yearS&P 500 per year
1 month+1.0%-4.3%+5.3 pts
3 months-33.3%-4.6%−28.7 pts
Year to date-61.3%+7.9%−69.2 pts
1 year-69.1%+11.8%−80.9 pts
3 years-99.5%+68.0%−167.5 pts-83.3%+18.9%
5 years-100.0%+66.2%−166.2 pts-81.3%+10.7%

How much it moves

Volatility, 1 year67.6%vs 80.6%
Volume against its 90-day average0.30vs 0.87

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M MBIO shares were sold short on Oct 30, 2026, up 19.3% from the previous report, or 1.00% of the shares available to trade. At recent volumes it would take 2.8 days to buy them back. Over the last 20 sessions, 31.0% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float1.00%vs 8.89%
Short interest as a share of all shares0.93%vs 6.30%
Days of volume to buy it back2.76vs 5.13

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202670,238+19.3%25,4492.8
Oct 15, 202658,855+11.7%54,4651.1
Sep 30, 202652,680-10.0%31,2051.7
Sep 15, 202658,509+6.3%23,4982.5
Aug 31, 202655,039+4.7%15,5053.5
Aug 14, 202652,568-4.7%36,8291.4
Jul 31, 202655,145-9.4%28,7311.9
Jul 15, 202660,867-40.6%41,9801.4
Jun 30, 2026102,440-32.0%49,5762.1
Jun 15, 2026150,627+176.0%553,9981.0
May 29, 202654,570+1.8%45,5451.2
May 15, 202653,594-25.7%40,8471.3

Every measure, in full

54 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 18, 2026

Valuation ratiosIndustry

Market Cap
$2.88M
$248.90M
Enterprise Value
-$12.27M
$131.42M
PB Ratio
0.38
1.96
P/TBV Ratio
0.38
2.22

Share statisticsIndustry

Shares Change (YoY)
202.2%
11.0%
Float
7M
49M
Shares Held by Insiders
7.12%
11.1%
Shares Held by Institutions
7.11%
56.3%

Short sellingIndustry

Short Interest
70,238
–
Short Interest Change
19.3%
-0.80%
Short % of Float
1.00%
8.89%
Short % of Shares Outstanding
0.93%
6.30%
Days to Cover
2.76
5.13

Stock price statisticsIndustry

52-Week High
$1.43
–
52-Week Low
$0.35
–
20-Day Moving Average
$0.40
–
50-Day Moving Average
$0.44
–
200-Day Moving Average
$0.65
–
Average True Range (14)
$0.03
–
Price Change (1 Week)
-11.2%
-9.78%
Price Change (1 Month)
0.13%
-10.5%
Price Change (3 Months)
-33.7%
-26.0%
Price Change (6 Months)
-38.0%
-24.7%
Price Change (YTD)
-61.3%
-26.8%
Price Change (1 Year)
-67.2%
-24.8%
Price Change (3 Years)
-99.5%
-32.3%
Price Change (5 Years)
-100.0%
-77.8%
Average Volume (10 Days)
43,438
–
Average Volume (20 Days)
34,643
–
Average Volume (90 Days)
32,189
–
Relative Volume
0.30
0.87
Relative Strength Index (14)
42.6
40.3
Volatility (1 Year)
67.6%
80.6%

Returns on capitalIndustry

Return on Equity (ROE)
-58.1%
-53.3%
Return on Assets (ROA)
-21.2%
-40.6%
Return on Capital Employed (ROCE)
-45.8%
-38.7%

Financial positionIndustry

Quick Ratio
1.91
2.37

EfficiencyIndustry

Profits Per Employee
-$758.25K
-$704.12K
Employee Count
4
75

Income statement (TTM)Industry

Operating Income
-$3.52M
-$21.49M
Net Income
-$3.03M
-$22.47M
EBITDA
-$3.52M
-$17.14M
EPS (Diluted)
-$0.45
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$15.15M
$15.31M
Net Cash Per Share
$2.00
$0.72
Equity (Book Value)
$7.55M
$49.40M
Book Value Per Share
$1.00
$1.45
Tangible Book Value
$7.55M
$23.58M

Cash flow (TTM)Industry

Operating Cash Flow
-$4.51M
-$12.15M

Dividends and yieldsIndustry

Earnings Yield
-105.3%
-23.6%

Scores and fair valueIndustry

Altman Z-Score
-36.46
0.11
Piotroski F-Score
3
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?